News

Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
23andMe Judge Questions Limits for New Auction for Bankrupt Firm
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...
23andMe’s Former CEO Pushes Purchase Price Nearly $50 Million Higher
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
Fierce Biotech5d
23andMe's Anne Wojcicki pushes to reopen auction with backing from Fortune 500 company
The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Des Moines Register7d
Regeneron is trying to buy 23andMe – and by extension, your DNA information | Opinion
Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 ...
STAT5dOpinion
I worked at 23andMe during its collapse. Here’s what the next consumer-genomics giant needs to understand
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
23andMe sold out and sold your genetic info, no consent necessary
We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...